Haemostasis Scientific Leadership
The primary mission of Stago Group Research & Development (R&D) division is to develop products and solutions (automatic analysers, reagents, consumables, services, etc.) that meet the needs of biomedical scientists and clinicians, with the goal of improving treatment for haemostasis and thrombosis. Working alongside the scientific community, R&D also focuses on identifying and studying new markers and new exploration pathways in the area of IVD and Haemostasis.
Since 1962, Stago Group has concentrated its attention on biomedical science, specialising in the “emerging” sector of Haemostasis. Thanks to this clear focus, the group is now recognized worldwide by one of leading player in scientific Haemostasis community.
Innovation technique

From CLSI Guidelines (H21-A5, 2008), they recommend that Lab should be use the Viscosity Based detection systems to guarantee the quality coagulation assays result:
Processing suitable Specimens for Plasma-Based Coagulation Assays
Some current instruments using an optical end-point determination may have problems with samples that are icteric, lipemic, or contain substance that interfere with light transmission. Ultracentrifugation has been suggested in some circumstances; however, there are no published studies. In a small, unpublished study of lipemic samples, PT and APTT assays were decreased and fibrinogen levels were increased by about 10% to 15%. Until published studies are performed or the laboratory has validated the procedure, mechanical and/or electromechanical methods for clot detection should be utilized when possible for these samples that are icteric, lipemic, or contain substances that interfere with light transmission.

Webinar
Recognized by the international scientific community for its essential contribution to advances in Haemostasis, Stago is committed to provide you with the latest relevant information regarding new tests, new markers or key assays in the field of Thrombosis and Haemostasis. These educational sessions will be provided by healthcare professionals and international world-renowned experts in the field.
Topic: Automate algorithms in the coag lab _ Expert rules for lupus anticoagulant testing, click here: http://www.stagowebinars.com/replay.php?idwebinar=58)
Topic: Recent challenges in laboratory monitoring of heamophilia treatment, click here: http://www.stagowebinars.com/replay.php?idwebinar=67
Topic: Coagulation alterations and management of patients with COVID – 19 infection, click here: http://www.stagowebinars.com/replay.php?idwebinar=68
And many topics for your exploring, visit here: http://www.stagowebinars.com/index.php